Fig. 9From: Synthesis, characterization, DNA binding interactions, DFT calculations, and Covid-19 molecular docking of novel bioactive copper(I) complexes developed via unexpected reduction of azo-hydrazo ligandsCartoon representation of (I) Estrogen Receptor Alpha Ligand Binding Domain, and, (II) SARS-CoV Mpro protein structures with (A) PCHD, (B) PyCHD, (C) [Cu(PCHD)2]ClO4.H2O and (D) [Cu(PyCHD)2]ClO4.H2OBack to article page